Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population

As part of a broader collaborative network of exome sequencing studies, we developed a jointly called data set of 5,685 Ashkenazi Jewish exomes. We make publicly available a resource of site and allele frequencies, which should serve as a reference for medical genetics in the Ashkenazim. We estimate that 30% of protein-coding alleles present in the Ashkenazi Jewish population at frequencies greater than 0.2% are significantly more frequent (mean 7.6-fold) than their maximum frequency observed in other reference populations. Arising via a well-described founder effect, this catalog of enriched alleles can contribute to differences in genetic risk and overall prevalence of diseases between populations. As validation we document 151 AJ enriched protein-altering alleles that overlap with “pathogenic” ClinVar alleles, including those that account for 10-100 fold differences in prevalence between AJ and non-AJ populations of some rare diseases including Gaucher disease (GBA, p.Asn409Ser, 8-fold enrichment); Canavan disease (ASPA, p.Glu285Ala, 12-fold enrichment); and Tay-Sachs disease (HEXA, c.1421+1G>C, 27-fold enrichment; p.Tyr427IlefsTer5, 12-fold enrichment). We next sought to use this catalog, of well-established relevance to Mendelian disease, to explore Crohn’s disease, a common disease with an estimated two to four-fold excess prevalence in AJ. We specifically evaluate whether strong acting rare alleles, enriched by the same founder-effect, contribute excess genetic risk to Crohn’s disease in AJ, and find that ten rare genetic risk factors in NOD2 and LRRK2 are strongly enriched in AJ, including several novel contributing alleles, show evidence of association to CD. Independently, we find that genomewide common variant risk defined by GWAS shows a strong difference between AJ and non-AJ European control population samples (0.97 s.d. higher, p<10−16). Taken together, the results suggest coordinated selection in AJ population for higher CD risk alleles in general. The results and approach illustrate the value of exome sequencing data in case-control studies along with reference data sets like ExAC to pinpoint genetic variation that contributes to variable disease predisposition across populations.

[1]  N. Risch,et al.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection. , 2003, American journal of human genetics.

[2]  A. Raftery.  Bayesian Model Selection in Social Research , 1995 .

[3]  Masa Umicevic Mirkov,et al.  Association mapping of inflammatory bowel disease loci to single variant resolution , 2015, bioRxiv.

[4]  Michael Boehnke,et al.  Recommended Joint and Meta‐Analysis Strategies for Case‐Control Association Testing of Single Low‐Count Variants , 2013, Genetic epidemiology.

[5]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[6]  J. Ioannidis,et al.  Estimating the contribution of genetic variants to difference in incidence of disease between population groups , 2012, European Journal of Human Genetics.

[7]  Ann Saada,et al.  Hypomyelination and developmental delay associated with VPS11 mutation in Ashkenazi-Jewish patients , 2015, Journal of Medical Genetics.

[8]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[9]  M. Daly,et al.  Searching for missing heritability: Designing rare variant association studies , 2014, Proceedings of the National Academy of Sciences.

[10]  Jon Wakefield,et al.  A Bayesian measure of the probability of false discovery in genetic epidemiology studies. , 2007, American journal of human genetics.

[11]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[12]  Kenneth Lange,et al.  Use of population isolates for mapping complex traits , 2000, Nature Reviews Genetics.

[13]  N. Treff,et al.  A deleterious mutation in the PEX2 gene causes Zellweger syndrome in individuals of Ashkenazi Jewish descent , 2014, Clinical genetics.

[14]  Q. Zhang,et al.  Commensal bacteria direct selective cargo sorting to promote symbiosis , 2015, Nature Immunology.

[15]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[16]  W. Lai,et al.  Epidemiology and Disease Burden of Ulcerative Colitis in Taiwan: A Nationwide Population-Based Study. , 2013, Value in health regional issues.

[17]  M. Färkkilä,et al.  CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn’s disease , 2003, Gut.

[18]  J. Al-Aama,et al.  A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes , 2014, Nature.

[19]  I. Leodolter.  [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.

[20]  Daniel G. MacArthur,et al.  The ExAC browser: displaying reference data information from over 60 000 exomes , 2016, bioRxiv.

[21]  Beryl B. Cummings,et al.  A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis , 2015, Nature Communications.

[22]  David Firth,et al.  Amendments and Corrections: Bias Reduction of Maximum Likelihood Estimates , 1995 .

[23]  Gonçalo R. Abecasis,et al.  Unified representation of genetic variants , 2015, Bioinform..

[24]  M. Färkkilä,et al.  Novel CARD15/NOD2 mutations in Finnish patients with Crohn's disease and their relation to phenotypic variation in vitro and in vivo , 2008, Inflammatory bowel diseases.

[25]  M. Netea,et al.  Genomewide association study of leprosy. , 2010, The New England journal of medicine.

[26]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[27]  D. Abeliovich,et al.  Carrier frequency of two BBS2 mutations in the Ashkenazi population , 2014, Clinical genetics.

[28]  Orli G. Bahcall.  Rare variant association studies , 2014, Nature Genetics.

[29]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[30]  Jennifer Mulle,et al.  A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci , 2012, PLoS genetics.

[31]  K. Kidd,et al.  Crohn's disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variation. , 2012, Molecular biology and evolution.

[32]  M. Knowles,et al.  Carrier frequencies of eleven mutations in eight genes associated with primary ciliary dyskinesia in the Ashkenazi Jewish population , 2014, Molecular genetics & genomic medicine.

[33]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[34]  D. Reich,et al.  Dominance of Deleterious Alleles Controls the Response to a Population Bottleneck , 2015, PLoS genetics.

[35]  Dr R B McCONNEDL.  The Genetics of Inflammatory Bowel Disease , 1979 .

[36]  M. Pilkington,et al.  The Indian Scenario , 2017 .

[37]  B. Pletcher,et al.  Carrier screening in individuals of Ashkenazi Jewish descent , 2008, Genetics in Medicine.

[38]  G. Hannon,et al.  Joubert syndrome 2 (JBTS2) in Ashkenazi Jews is associated with a TMEM216 mutation. , 2010, American journal of human genetics.

[39]  Ying Wang,et al.  Genomewide association study of leprosy. , 2009, The New England journal of medicine.

[40]  Matti Pirinen,et al.  Imputation-Based Meta-Analysis of Severe Malaria in Three African Populations , 2013, PLoS genetics.

[41]  R. Newcombe,et al.  Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. , 1980, British medical journal.

[42]  H. Ostrer.  A genetic profile of contemporary Jewish populations , 2001, Nature Reviews Genetics.

[43]  Francisco M. De La Vega,et al.  Genomics for the world , 2011, Nature.

[44]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[45]  G. Liguori,et al.  Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[46]  Stephen C. J. Parker,et al.  The genetic architecture of type 2 diabetes , 2016, Nature.

[47]  A Wajda,et al.  Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. , 1999, American journal of epidemiology.

[48]  V. Mohan,et al.  Epidemiology of type 2 diabetes: Indian scenario. , 2007, The Indian journal of medical research.

[49]  Judy H. Cho,et al.  Expanded genetic screening panel for the Ashkenazi Jewish population , 2015, Genetics in Medicine.

[50]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[51]  Kenneth Offit,et al.  Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins , 2014, Nature Communications.

[52]  R. Sandier.  The epidemiology of inflammatory bowel disease , 1990 .

[53]  Y. Okada,et al.  Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy , 2015, Nature Genetics.

[54]  D. Firth.  Bias reduction of maximum likelihood estimates , 1993 .

[55]  Cameron D. Palmer,et al.  Evidence of widespread selection on standing variation in Europe at height-associated SNPs , 2012, Nature Genetics.

[56]  Joshua M. Korn,et al.  Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease , 2011, Nature Genetics.

[57]  A. Auvinen,et al.  Incidence of inflammatory bowel disease in finnish children, 1987–2003 , 2006, Inflammatory bowel diseases.

[58]  P. Gros,et al.  A common genetic fingerprint in leprosy and Crohn's disease? , 2009, The New England journal of medicine.

[59]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[60]  W. Chung,et al.  Founder Fukutin mutation causes Walker–Warburg syndrome in four Ashkenazi Jewish families , 2009, Prenatal diagnosis.

[61]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[62]  Gil McVean,et al.  Demography and the Age of Rare Variants , 2014, PLoS genetics.

[63]  Andres Metspalu,et al.  Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population , 2014, PLoS genetics.

[64]  W. Sandborn,et al.  Crohn's disease , 2012, The Lancet.

[65]  S. Bale,et al.  Leukoencephalopathy and early death associated with an Ashkenazi-Jewish founder mutation in the Hikeshi gene , 2015, Journal of Medical Genetics.

[66]  H. Ostrer,et al.  The population genetics of the Jewish people , 2012, Human Genetics.

[67]  A. Ekbom,et al.  Epidemiology of inflammatory bowel disease , 1992, Current opinion in gastroenterology.

[68]  R. Gershoni-baruch,et al.  Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. , 2003, The Journal of pediatrics.